First Time Loading...
S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 28.8 CNY 1.02% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shandong Pharmaceutical Glass Co Ltd

Wall Street analysts forecast Shandong Pharmaceutical Glass Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Pharmaceutical Glass Co Ltd is 35.02 CNY with a low forecast of 34.34 CNY and a high forecast of 36.75 CNY.

Lowest Forecast
Wall Street Target
34.34 CNY
19% Upside
Average Forecast
Wall Street Target
35.02 CNY
22% Upside
Highest Forecast
Wall Street Target
36.75 CNY
28% Upside
Lowest
Price Target
34.34 CNY
19% Upside
Average
Price Target
35.02 CNY
22% Upside
Highest
Price Target
36.75 CNY
28% Upside
Shandong Pharmaceutical Glass Co Ltd Competitors:
Price Targets
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
20% Upside
7447
Nagaileben Co Ltd
13% Downside
S
1501
Shanghai Kindly Medical Instruments Co Ltd
29% Upside
ESTA
Establishment Labs Holdings Inc
27% Upside
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
20% Upside
7447
Nagaileben Co Ltd
13% Downside
S
1501
Shanghai Kindly Medical Instruments Co Ltd
29% Upside
ESTA
Establishment Labs Holdings Inc
27% Upside
ALC
Alcon AG
18% Upside
T
TOG
Thai Optical Group PCL
45% Downside
O
KIDS
OrthoPediatrics Corp
35% Upside
POLYMED
Poly Medicure Ltd
4% Downside

Revenue
Forecast

Revenue Estimate
Shandong Pharmaceutical Glass Co Ltd

For the last 8 years the compound annual growth rate for Shandong Pharmaceutical Glass Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 16%.

12%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shandong Pharmaceutical Glass Co Ltd

For the last 8 years the compound annual growth rate for Shandong Pharmaceutical Glass Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 23%.

19%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shandong Pharmaceutical Glass Co Ltd

For the last 8 years the compound annual growth rate for Shandong Pharmaceutical Glass Co Ltd's net income is 22%. The projected CAGR for the next 3 years is 24%.

22%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Pharmaceutical Glass Co Ltd's stock price target?
Price Target
35.02 CNY

According to Wall Street analysts, the average 1-year price target for Shandong Pharmaceutical Glass Co Ltd is 35.02 CNY with a low forecast of 34.34 CNY and a high forecast of 36.75 CNY.

What is Shandong Pharmaceutical Glass Co Ltd's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Shandong Pharmaceutical Glass Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 16%.

What is Shandong Pharmaceutical Glass Co Ltd's Operating Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Shandong Pharmaceutical Glass Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 23%.

What is Shandong Pharmaceutical Glass Co Ltd's Net Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Shandong Pharmaceutical Glass Co Ltd's net income is 22%. The projected CAGR for the next 3 years is 24%.

ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.